Search alternatives:
linear decrease » linear increase (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a large » _ large (Expand Search)
linear decrease » linear increase (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a large » _ large (Expand Search)
-
10701
-
10702
-
10703
-
10704
-
10705
-
10706
<i>trkA</i> gene inactivation decreases <i>E</i>. <i>coli</i> intracellular K<sup>+</sup> concentration.
Published 2016“…<p><i>trkA</i> gene inactivation decreases <i>E</i>. <i>coli</i> intracellular K<sup>+</sup> concentration.…”
-
10707
-
10708
-
10709
-
10710
-
10711
-
10712
-
10713
Down-Regulation of Annexin A Proteins in Human Mesangial Cells by TEGDMA and Bis-GMA Treatment Disrupts Proteins Involved in Cellular Function
Published 2025“…Transient knockdown of annexin A2 protein expression using annexin A2 siRNA resulted in a significant decrease in alpha smooth muscle actin and non-muscle myosin protein expression in human mesangial cells when compared to cells transfected with non-targeting control siRNA. …”
-
10714
-
10715
Image_1_Respiratory Syncytial Virus Exacerbates Kidney Damages in IgA Nephropathy Mice via the C5a-C5aR1 Axis Orchestrating Th17 Cell Responses.pdf
Published 2019“…These pathological behaviors were augmented by C5a stimulation and decreased by C5aR1 inhibition. …”
-
10716
Image_1_Respiratory Syncytial Virus Exacerbates Kidney Damages in IgA Nephropathy Mice via the C5a-C5aR1 Axis Orchestrating Th17 Cell Responses.pdf
Published 2019“…These pathological behaviors were augmented by C5a stimulation and decreased by C5aR1 inhibition. …”
-
10717
-
10718
-
10719
Adverse events <sup>a</sup>.
Published 2024“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
-
10720